ARTL
Price
$0.77
Change
+$0.01 (+1.32%)
Updated
Jul 31 closing price
Capitalization
2.68M
10 days until earnings call
Intraday BUY SELL Signals
PALI
Price
$1.90
Change
-$0.07 (-3.57%)
Updated
Jul 31 closing price
Capitalization
329.31M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARTL vs PALI

ARTL vs PALI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARTL vs. PALI commentary
Aug 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTL is a Hold and PALI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2026
Stock price -- (ARTL: $0.77 vs. PALI: $1.89)
Brand notoriety: ARTL and PALI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTL: 35% vs. PALI: 40%
Market capitalization -- ARTL: $2.68M vs. PALI: $329.31M
ARTL [@Biotechnology] is valued at $2.68M. PALI’s [@Biotechnology] market capitalization is $329.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTL’s FA Score shows that 1 FA rating(s) are green whilePALI’s FA Score has 0 green FA rating(s).

  • ARTL’s FA Score: 1 green, 4 red.
  • PALI’s FA Score: 0 green, 5 red.
According to our system of comparison, PALI is a better buy in the long-term than ARTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTL’s TA Score shows that 4 TA indicator(s) are bullish while PALI’s TA Score has 5 bullish TA indicator(s).

  • ARTL’s TA Score: 4 bullish, 4 bearish.
  • PALI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ARTL and PALI are a good buy in the short-term.

Price Growth

ARTL (@Biotechnology) experienced а -24.51% price change this week, while PALI (@Biotechnology) price change was -2.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

ARTL is expected to report earnings on Aug 12, 2026.

PALI is expected to report earnings on Aug 25, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PALI($329M) has a higher market cap than ARTL($2.68M). PALI YTD gains are higher at: -19.362 vs. ARTL (-78.962). ARTL has higher annual earnings (EBITDA): -13.06M vs. PALI (-24.14M). PALI has more cash in the bank: 133M vs. ARTL (10.3M). PALI has less debt than ARTL: PALI (211K) vs ARTL (719K). ARTL (0) and PALI (0) have equivalent revenues.
ARTLPALIARTL / PALI
Capitalization2.68M329M1%
EBITDA-13.06M-24.14M54%
Gain YTD-78.962-19.362408%
P/E RatioN/A15.79-
Revenue00-
Total Cash10.3M133M8%
Total Debt719K211K341%
FUNDAMENTALS RATINGS
ARTL vs PALI: Fundamental Ratings
ARTL
PALI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9642
P/E GROWTH RATING
1..100
10048
SEASONALITY SCORE
1..100
9027

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARTL's Valuation (7) in the null industry is somewhat better than the same rating for PALI (69). This means that ARTL’s stock grew somewhat faster than PALI’s over the last 12 months.

ARTL's Profit vs Risk Rating (100) in the null industry is in the same range as PALI (100). This means that ARTL’s stock grew similarly to PALI’s over the last 12 months.

PALI's SMR Rating (98) in the null industry is in the same range as ARTL (100). This means that PALI’s stock grew similarly to ARTL’s over the last 12 months.

PALI's Price Growth Rating (42) in the null industry is somewhat better than the same rating for ARTL (96). This means that PALI’s stock grew somewhat faster than ARTL’s over the last 12 months.

PALI's P/E Growth Rating (48) in the null industry is somewhat better than the same rating for ARTL (100). This means that PALI’s stock grew somewhat faster than ARTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARTLPALI
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 19 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ARTL
Daily Signal:
Gain/Loss:
PALI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAA132.34-0.98
-0.74%
Mid-America Apartment Communities
CHGA0.19N/A
-0.88%
Change Agents Corporation
ESTA92.54-0.94
-1.01%
Establishment Labs Holdings
PRTH6.50-0.11
-1.66%
Priority Technology Holdings
SERA2.04-0.06
-2.86%
Sera Prognostics

ARTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTL has been loosely correlated with PALI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTL jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTL
1D Price
Change %
ARTL100%
+1.96%
PALI - ARTL
34%
Loosely correlated
-3.32%
CRMD - ARTL
32%
Poorly correlated
+0.53%
FATE - ARTL
31%
Poorly correlated
-2.39%
LSTA - ARTL
29%
Poorly correlated
-3.88%
SPRO - ARTL
28%
Poorly correlated
-2.50%
More

PALI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PALI has been closely correlated with RNAC. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if PALI jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PALI
1D Price
Change %
PALI100%
-3.32%
RNAC - PALI
81%
Closely correlated
+0.91%
AGEN - PALI
81%
Closely correlated
-5.18%
NCNA - PALI
81%
Closely correlated
+4.76%
TAOX - PALI
81%
Closely correlated
-2.66%
NRXP - PALI
74%
Closely correlated
+0.96%
More